265 related articles for article (PubMed ID: 19674100)
1. Recombinant expression of an insulin-like peptide 3 (INSL3) precursor and its enzymatic conversion to mature human INSL3.
Luo X; Bathgate RA; Liu YL; Shao XX; Wade JD; Guo ZY
FEBS J; 2009 Sep; 276(18):5203-11. PubMed ID: 19674100
[TBL] [Abstract][Full Text] [Related]
2. Design and recombinant expression of insulin-like peptide 5 precursors and the preparation of mature human INSL5.
Luo X; Bathgate RA; Zhang WJ; Liu YL; Shao XX; Wade JD; Guo ZY
Amino Acids; 2010 Nov; 39(5):1343-52. PubMed ID: 20383778
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and pharmacological evaluation of cyclic mimetics of the insulin-like peptide 3 (INSL3) B-chain.
Shabanpoor F; Bathgate RA; Hossain MA; Giannakis E; Wade JD; Hughes RA
J Pept Sci; 2007 Feb; 13(2):113-20. PubMed ID: 17120268
[TBL] [Abstract][Full Text] [Related]
4. Design and development of analogues of dimers of insulin-like peptide 3 B-chain as high-affinity antagonists of the RXFP2 receptor.
Shabanpoor F; Zhang S; Hughes RA; Hossain MA; Layfield S; Ferraro T; Bathgate RA; Separovic F; Wade JD
Biopolymers; 2011; 96(1):81-7. PubMed ID: 20560146
[TBL] [Abstract][Full Text] [Related]
5. Solid-phase synthesis of europium-labeled human INSL3 as a novel probe for the study of ligand-receptor interactions.
Shabanpoor F; Hughes RA; Bathgate RA; Zhang S; Scanlon DB; Lin F; Hossain MA; Separovic F; Wade JD
Bioconjug Chem; 2008 Jul; 19(7):1456-63. PubMed ID: 18529069
[TBL] [Abstract][Full Text] [Related]
6. Role of the intra-A-chain disulfide bond of insulin-like peptide 3 in binding and activation of its receptor, RXFP2.
Zhang S; Hughes RA; Bathgate RA; Shabanpoor F; Hossain MA; Lin F; van Lierop B; Robinson AJ; Wade JD
Peptides; 2010 Sep; 31(9):1730-6. PubMed ID: 20570702
[TBL] [Abstract][Full Text] [Related]
7. Chemical synthesis and biological activity of rat INSL3.
Smith KJ; Wade JD; Claasz AA; Otvos L; Temelcos C; Kubota Y; Hutson JM; Tregear GW; Bathgate RA
J Pept Sci; 2001 Sep; 7(9):495-501. PubMed ID: 11587188
[TBL] [Abstract][Full Text] [Related]
8. Leucine-rich repeat-containing G-protein-coupled receptor 8 in mature glomeruli of developing and adult rat kidney and inhibition by insulin-like peptide-3 of glomerular cell proliferation.
Fu P; Shen PJ; Zhao CX; Scott DJ; Samuel CS; Wade JD; Tregear GW; Bathgate RA; Gundlach AL
J Endocrinol; 2006 May; 189(2):397-408. PubMed ID: 16648305
[TBL] [Abstract][Full Text] [Related]
9. The active form of goat insulin-like peptide 3 (INSL3) is a single-chain structure comprising three domains B-C-A, constitutively expressed and secreted by testicular Leydig cells.
Siqin ; Minagawa I; Okuno M; Yamada K; Sugawara Y; Nagura Y; Hamano K; Park EY; Sasada H; Kohsaka T
Biol Chem; 2013 Sep; 394(9):1181-94. PubMed ID: 23934571
[TBL] [Abstract][Full Text] [Related]
10. Effect of helix-promoting strategies on the biological activity of novel analogues of the B-chain of INSL3.
Shabanpoor F; Hughes RA; Zhang S; Bathgate RA; Layfield S; Hossain MA; Tregear GW; Separovic F; Wade JD
Amino Acids; 2010 Jan; 38(1):121-31. PubMed ID: 19067106
[TBL] [Abstract][Full Text] [Related]
11. The "hot wires" of the relaxin-like factor (Insl3).
Schwabe C; Büllesbach EE
Ann N Y Acad Sci; 2009 Apr; 1160():93-8. PubMed ID: 19416166
[TBL] [Abstract][Full Text] [Related]
12. Relaxin-3, INSL5, and their receptors.
Liu C; Lovenberg TW
Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human insulin. VIII. Isolation of fusion protein--S-sulfonate, biotechnological precursor of human insulin, from the biomass of transformed Escherichia coli cells.
Tikhonov RV; Pechenov SE; Belacheu IA; Yakimov SA; Klyushnichenko VE; Boldireva EF; Korobko VG; Tunes H; Thiemann JE; Vilela L; Wulfson AN
Protein Expr Purif; 2001 Feb; 21(1):176-82. PubMed ID: 11162404
[TBL] [Abstract][Full Text] [Related]
14. Human gene 2 relaxin chain combination and folding.
Tang JG; Wang ZH; Tregear GW; Wade JD
Biochemistry; 2003 Mar; 42(9):2731-9. PubMed ID: 12614168
[TBL] [Abstract][Full Text] [Related]
15. A simple approach for the preparation of mature human relaxin-3.
Luo X; Liu YL; Layfield S; Shao XX; Bathgate RA; Wade JD; Guo ZY
Peptides; 2010 Nov; 31(11):2083-8. PubMed ID: 20688116
[TBL] [Abstract][Full Text] [Related]
16. Sequences of B-chain/domain 1-10/1-9 of insulin and insulin-like growth factor 1 determine their different folding behavior.
Chen Y; You Y; Jin R; Guo ZY; Feng YM
Biochemistry; 2004 Jul; 43(28):9225-33. PubMed ID: 15248780
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like factor 3: where are we now?
Ivell R; Hartung S; Anand-Ivell R
Ann N Y Acad Sci; 2005 May; 1041():486-96. PubMed ID: 15956750
[TBL] [Abstract][Full Text] [Related]
18. Refolding of amphioxus insulin-like peptide: implications of a bifurcating evolution of the different folding behavior of insulin and insulin-like growth factor 1.
Wang S; Guo ZY; Shen L; Zhang YJ; Feng YM
Biochemistry; 2003 Aug; 42(32):9687-93. PubMed ID: 12911310
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like peptide 3 expressed in the silkworm possesses intrinsic disulfide bonds and full biological activity.
Miyazaki T; Ishizaki M; Dohra H; Park S; Terzic A; Kato T; Kohsaka T; Park EY
Sci Rep; 2017 Dec; 7(1):17339. PubMed ID: 29229959
[TBL] [Abstract][Full Text] [Related]
20. The human insulin superfamily of polypeptide hormones.
Shabanpoor F; Separovic F; Wade JD
Vitam Horm; 2009; 80():1-31. PubMed ID: 19251032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
